Ellington Management Group’s Idexx Laboratories IDXX Stock Holding History

Ellington Management Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,700	Closed	-$370K	–	581
2018 Q2	$370K	Buy	+1,700	New	+$350K	0.03%	233
2017 Q2	–	Sell	-1,700	Closed	-$263K	–	758
2017 Q1	$263K	Sell	1,700 -300	-15%	-$41.4K	0.01%	494
2016 Q4	$235K	Sell	2,000 -1,700	-46%	-$194K	0.04%	390
2016 Q3	$417K	Buy	+3,700	New	+$390K	0.11%	343
2014 Q3	–	Sell	-4,000	Closed	-$267K	–	369
2014 Q2	$267K	Buy	+4,000	New	+$254K	0.12%	267

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Ellington Management Group's IDXX Position: Q3 2018 in Review

Ellington Management Group sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 1,700 shares — an estimated $370K sold.

Ellington Management Group first reported a position in IDXX in Q2 2014 and held it in 5 quarters. The position peaked at $417K in Q3 2016. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

Ellington Management Group reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
Ellington Management Group sold 1,700 Idexx Laboratories shares in Q3 2018, an estimated $370K.
Ellington Management Group first reported a position in Idexx Laboratories in Q2 2014 and held it in 5 quarters.
Ellington Management Group's Idexx Laboratories position peaked at $417K in Q3 2016.
698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Ellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.